Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Mixed Connective Tissue Disease (MCTD): early-phase trial registry

1 of 1 indexed Mixed Connective Tissue Disease (MCTD) trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Mixed Connective Tissue Disease (MCTD): 1 US clinical trial tracked, 1 recruiting.

Mixed Connective Tissue Disease (MCTD) is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Robyn T. Domsic, MD, MPH, running 1 of these trials.

Enrollment posture brief

Registry condition mixed-connective-tissue-disease-mctd

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Mixed Connective Tissue (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Mixed Connective Tissue Disease (MCTD)

Mixed Connective Tissue Disease (MCTD) lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Mixed Connective Tissue Disease (MCTD) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Mixed Connective Tissue Disease (MCTD) is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Named interventions

Most-linked intervention names on Mixed Connective Tissue Disease (MCTD) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Sodium Thiosulfate (STS) Drug
1 trials

US sites by state

Facility locations filed on Mixed Connective Tissue Disease (MCTD) trials. A trial with sites in several states counts in each.

Pennsylvania 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Mixed Connective Tissue Disease (MCTD) page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Mixed Connective Tissue Disease (MCTD) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Robyn T. Domsic, MD, MPH sponsors the most Mixed Connective Tissue Disease (MCTD) trials on record, review their full trial history before evaluating a specific study. See Robyn T. Domsic, MD, MPH's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Mixed Connective Tissue Disease (MCTD) condition card totals 1 registered trials; most-linked intervention Sodium Thiosulfate (STS); top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.